Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
Am J Med Sci
.
2019 Aug;358(2):91-92.
doi: 10.1016/j.amjms.2019.04.029.
Epub 2019 Jun 15.
Author
Tuomas O Kiviniemi
1
Affiliation
1
Heart Center, Turku University Hospital, University of Turku, Turku, Finland; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: tuoski@utu.fi.
PMID:
31331457
DOI:
10.1016/j.amjms.2019.04.029
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants
Atrial Fibrillation*
Fibrinolytic Agents
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Substances
Anticoagulants
Fibrinolytic Agents
Platelet Aggregation Inhibitors